Case 1 – The PCSK9 inhibitor case: What is “sufficient disclosure”?

In this case, we will discuss the topic of sufficient disclosure in the context of patenting an antibody. For the purposes of this case study, you will play the role of a legal advisor working in the IP department at a company that recently developed “Cholowerol”, an antibody that binds PCSK9 and is designed to treat high cholesterol.